Emkay Global Financial is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 835 in its research report dated June 04, 2020.
Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 880 in its research report dated June 04, 2020.
Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 840 in its research report dated June 04, 2020.
Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 838 in its research report dated June 05, 2020.
HDFC Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 835 in its research report dated June 05, 2020.
ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 920 in its research report dated May 05, 2020.
ICICI Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 870 in its research report dated June 04, 2020.
Emkay Global Financial is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 786 in its research report dated June 03, 2020.
HDFC Securities bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 790 in its research report dated May 13, 2020.
Prabhudas Lilladher recommended Hold rating on Aurobindo Pharma with a target price of Rs 511 in its research report dated November 13, 2019.
Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 500 in its research report dated November 13, 2019.
Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 710 in its research report dated August 08, 2019.
ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 735 in its research report dated August 08, 2019.
Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 710 in its research report dated June 28, 2019.
HDFC Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 800 in its research report dated May 29, 2019.
Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 952 in its research report dated March 20, 2019.
Keynotes Financial Opiniery is bullish on Aurbindo Pharma has recommended buy rating on the stock with a target price of Rs 906 in its research report dated March 19, 2019.
ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 915 in its research report dated February 08, 2019.
Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 940 in its research report dated January 17, 2019.
HDFC Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 875 in its research report dated November 14, 2018.
Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 909 in its research report dated November 13, 2018.
Centrum is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1270 in its research report dated September 10, 2018.
Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 910 in its research report dated September 06, 2018.
Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 909 in its research report dated September 06, 2018.
ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 915 in its research report dated September 07, 2018.